bioRxivCancer BiologyPreprint
Inhibitory Properties of Cannabis sativa Seed Extract on Pancreatic Cancer Cells
Fatemeh Salah, Mohammad MasoudiiD, Forouzan Ghasemian Roudsari, Sadrollah RamezaniiD
Abstract
BackgroundPancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers and there is a pressing need for development of new therapies. Recently, cannabis has received attentions as a promising plant-based medication for treating a variety of illnesses. The studies investigating the anti-tumor effects of C. sativa extract, to date, have used the plant leaves. In this study, we explore the inhibitory properties of C. sativa seeds. MethodsAn ethanolic extract of C. sativa seeds was prepared. GC-MS analysis was performed to identify the compounds in the extract. The cytotoxicity of the extract on PANC-1 cells and HFF cells was assessed using MTT assay. Colony formation and Wound healing assays were used to evaluate the impact of the extract on the ability of PANC-1 cells to form colonies and migrate. Flow cytometry analysis evaluated cell cycle phase of PANC-1 cells after treatment with the extract. ResultsThe C. sativa seed extract had anti-proliferative effects on pancreatic cancer cells PANC-1, while showing no such an effect on normal HFF cells. The extract made its impact on PANC-1 cells by arresting them at G1 phase and increasing their apoptosis. Furthermore it inhibited PANC-1 colony formation and changed the colony combination in favor of paraclones. Migration capacity of PANC-1 cells was also attenuated by the extract. ConclusionsOur results revealed that C. sativa seed extract has inhibitory effects on PANC-1 cells by reducing their proliferation, migration and colony formation capacity. It halts the cells in G1 phase and increases their apoptosis.
- organism: human
- assay: bulk RNA-seq
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer
Sahar F. Bannoura, Husain Yar Khan, … Asfar S. Azmi·bioRxiv·Dec 10, 2025
- Semecarpus anacardium Linn. leaf extract exhibits activities against breast cancer and prolongs the survival of tumor-bearing mice
R. K. Singh, B. MALLIK, … A. K. Singh·bioRxiv·Jan 8, 2020
- KRAS Inhibition Reverses Chemotherapy Resistance Promoted by Therapy-Induced Senescence-like in Pancreatic Ductal Adenocarcinoma
Analía Meilerman Abuelafia, Patricia Santofimia‐Castaño, … Juan Iovanna·Translational OncologyPeer-reviewed·May 17, 2025
- Phenylethynylbenzyl-Modified Biguanides Inhibit Pancreatic Cancer Tumor Growth
A. Hebert, M. Parisotto, … A. Schmitzer·bioRxiv·Oct 7, 2019
- Differential Induction of Cancer Cell Death by Root, Leaf, and Flower Extracts derived from Kalanchoe pinnata
Mitsuki Maedomari, Sakura Kawada, Nanae Harashima·bioRxiv·May 30, 2026
- HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery
Gaoyang Liang, Hung V.‐T. Nguyen, … Ronald M. Evans·Proceedings of the National Academy of SciencesPeer-reviewed·Jun 25, 2026